Fig 2.
Time-dependent log hazard ratios for recurrence, infusional fluorouracil, leucovorin, oxaliplatin (FOLFOX) versus fluorouracil plus leucovorin (FU + LV), for (A) patients with stage II disease and (B) patients with stage III disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.